小児チック症診療ガイドライン

出版社： 診断と治療社
著者：
発行日： 2024-02-15
分野： 臨床医学：内科  >  小児科学一般
ISBN： 9784787825650
電子書籍版： 2024-02-15 （電子版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

3,300 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

3,300 円(税込)

購入する

商品紹介

短期間で軽快，消失する軽症例から，生活に支障をきたすトゥレット症とよばれる重症例まで幅広い症状をもち，子どもの5～10人に1人は経験するありふれた疾患であるチック症．本書は日本で初のチック症診療ガイドラインであり，チック症診療に携わる一般小児科医，小児神経専門医，児童精神専門医はじめ，そのほかの医療従事者，教育関係者にも必携の1冊です！

目次

  • 第1章　総論
    1　疾患トピックの基本的特徴
    　　COLUMN　Yale global tic severity scale（YGTSS）とpremonitory urge for tics scale（PUTS）
    　　COLUMN　溶連菌感染に伴う小児自己免疫性神経精神疾患（PANDAS）
    ◎診療アルゴリズム・フロー

    第2章　推奨
    CQ1　小児チック症として妥当な症状は何か？
    CQ2　どの時期に治療を開始することが推奨されるか？また，年齢を判断基準にすることが推奨されるか？
    CQ3　小児チック症への生活指導や疾病教育は推奨されるか？
    CQ4　小児チック症の環境調整は推奨されるか？
    CQ5　一般小児科医が初期治療として薬物治療（を行うこと）が推奨されるか？
    　　　　i．推奨される処方内容は？
    　　　　ii．漢方薬は推奨されるか？
    CQ6　小児チック症の治療に対する心理療法は推奨されるか？
    　　　　COLUMN　チック症のための包括的行動的介入（CBIT）と遠隔心理療法
    CQ7　小児チック症に併存するADHDの薬物治療に何が推奨されるか？
    CQ8　専門医につなぐことが推奨される時期はいつか？
    CQ9　小児チック症の診断に脳波検査/画像検査は推奨されるか？
    CQ10　小児チック症に伴うOCDに推奨される治療は何か？
    CQ11　専門医が行う本人・家族への生活指導内容で伝えることが推奨される内容は何か？
    CQ12　以下の薬剤は治療薬として推奨されるか？
    　　　　　・リスペリドン
    　　　　　・アリピプラゾール
    　　　　　・抗てんかん薬（トピラマート，レベチラセタム）
    　　　　　・極少量レボドパ療法 43
    　　　　　COLUMN　極少量レボドパ療法（0.5mg/kg/日）について
    CQ13　小児チック症に対するハビットリバーサル（HRT），チック症のための包括的行動的介入（CBIT）
    　　　　および曝露反応妨害法（ERP）は推奨されるか？
    　　　　　COLUMN　トゥレット症に対する呼吸法について
    　　　　　COLUMN　トゥレット症に対する歯科スプリント治療について
    　　　　　COLUMN　トゥレット症の脳深部刺激療法（DBS）について
    CQ14　内服治療の終了が推奨される時期はいつか？
    ◎資料：文献検索式・文献

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 総論

P.8 掲載の参考文献
1) American Psychiatric Association, 原著, 高橋三郎, 大野裕, 監訳. チック障害. DSM-5 精神疾患の分類と診断の手引. 東京 : 医学書院, 2014 : 37-41.
 
2) 星加明徳. チック, トゥレット障害の診断から治療まで. 柳澤正義, 監修. 田原卓浩, 編. メンタルヘルスケア. 東京 : 中山書店, 2004 : 58-9.
 
3) 星加明徳他. チック障害・トウレット障害. 星加明徳, 宮本信也, 編. よくわかる子どもの心身症. 東京 : 永井書店, 2003 : 202-14.
 
4) 金生由紀子. チック症/チック症候群. 精神医学症候群 I (第2版). 別冊日本臨牀 2017 ; 37 : 116-29.
 
5) 金生由紀子. チックとトゥレット症. こころの科学 2017 ; 194 : 14-7.
 
6) 融道男, 中根允文, 見山実, 岡崎祐士. 大久保善朗, 監訳. ICD-10 精神および行動の障害-臨床記述と診断ガイドライン. 東京 : 医学書院, 2005
 
7) 松田なつみ. チックの基本を理解する. 発達障害医学の進歩 2018 ; 30 : 8-18.
 
8) Ramkiran S, Heidemeyer L, Gaebler A, Shah NJ, Neuner I. Alterations in basal ganglia-cerebello-thalamo-cortical connectivity and whole brain functional network topology in Tourette's syndrome.Neuroimage Clin 2019 ; 24 : 101998.
PubMed
9) World Health Organization : ICD-11 for Mortality and Morbidity Statistics (Version : 02/2022) ICD-11 for Mortality and Morbidity Statistics (who.int)
 
10) 山下裕史朗. チック・トゥレット症とADHD・限局性学習症・自閉スペクトラム症. こころの科学 2017 ; 194 : 37-40.
 
11) 藤尾未由希. チックの早期アセスメントと支援. 発達障害医学の進歩 2018 ; 30 : 19-25.
 
12) Scahill L, Chappel PB, King RA, Leckman JF. Pharmacologic treatment of tic disorders. Child Adolesc Psychiatr Clin N Am 2000 ; 9 : 99-117.
 
13) 宮島祐, 星加明徳, 宮本信也. 小児薬物療法における医薬品の向精神薬適正使用の問題点の把握および対策に関する研究-日本小児精神神経学会・日本小児心身医学会会員への平成12年度アンケート調査結果から. 小児の精神と神経 2002 ; 42 : 75-81.
 
14) Hamamoto Y, Fujio M, Nonaka M, Matsuda N, Kono T, Kano Y. Expert consensus on pharmacotherapy for tic disorders in Japan. Brain Dev 2019 ; 41 : 501-6.
PubMed
15) Inoko K, Nishizono-Maher A, Tanima S, Kano Y, Kishimoto J, Hayakawa N, et al. Reliability and validity of a Japanese version of the Yale global tic severity scale : a preliminary study. Jpn J Child Adolesc Psychiatr 2006 ; 47 (Suppl) : 38-48.
 

第2章 推奨

P.14 掲載の参考文献
1) 梶龍兒, 編. 不随意運動の診断と治療, 改訂第2版. 東京 : 診断と治療社, 2016.
 
2) American Psychiatric Association, 著, 高橋三郎, 大野裕, 監訳, 日本精神神経学会 (日本語版用語監修). DSM-5 精神疾患の診断・統計マニュアル. 東京 : 医学書院, 2014.
 
3) Shapiro AK, Shapiro ES, Young JG, Feinberg TE, eds. Gilles de la Tourette syndrome. 2nd ed. New York : Raven Press, 1988.
 
4) Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale : initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989 ; 28 : 566-73.
PubMed
5) Freeman R. Tics and Tourette Syndrome : Key Clinical Perspectives. London : Mac Keith Press, 2015.
 
6) 稲見茉莉, 金生由紀子. チック症の評価. 小児科臨床 2019 ; 72 (増刊) : 1331-4.
 
7) Robertson MM, Althoff RR, Hafez A, Pauls DL. Principal components analysis of a large cohort with Tourette syndrome. Br J Psychiatry 2008 ; 193 : 31-6.
PubMed
8) Freeman RD, Zinner SH, Muller-Vahl KR, et al. Coprophenomena in Tourette syndrome. Dev Med Child Neurol 2009 ; 51 : 218-27.
PubMed
9) Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993 ; 150 : 98-102.
PubMed
P.16 掲載の参考文献
1) Shapiro AK, Shapiro ES, Young JG, Feinberg TE, eds. Gilles de la Tourette syndrome. 2nd ed. New York : Raven Press, 1988.
 
2) Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome : selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000 ; 42 : 436-47.
PubMed
3) Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res 2009 ; 67 : 497-501.
PubMed
4) Cavanna AE, Critchley HD, Orth M, Stern JS, Young MB, Robertson MM. Dissecting the Gilles de la Tourette spectrum : a factor analytic study on 639 patients. J Neurol Neurosurg Psychiatry 2011 ; 82 : 1320-3.
 
5) Stiede JT, Woods DW. Pediatric Prevention : Tic Disorders. Pediatr Clin North Am 2020 ; 67 : 547-57.
PubMed
6) Bernard BA, Stebbins GT, Siegel S, et al. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord 2009 ; 24 : 1070-3.
PubMed
7) Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome : the first two decades. Pediatrics 1998 ; 102 : 14-9.
PubMed
8) Rizzo R, Gulisano M, Cali PV, Curatolo P. Long term clinical course of Tourette syndrome. Brain Dev 2012 ; 34 : 667-73.
PubMed
9) Kuwabara H, Kono T, Shimada T, Kano Y. Factors affecting clinicians' decision as to whether to prescribe psychotropic medications or not in treatment of tic disorders. Brain Dev 2012 ; 34 : 39-44.
PubMed
10) Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary : treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 896-906.
PubMed
P.18 掲載の参考文献
1) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
2) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
3) Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 2018 ; 9 : 100.
PubMed
4) 金生由紀子. チック症, 吃音. 小児科診療 2018 ; 81 : 902-4.
Medical*Online
5) Hassan N, Cavanna AE. The prognosis of Tourette syndrome : implications for clinical practice. Funct Neurol 2012 ; 27 : 23-7.
PubMed
P.21 掲載の参考文献
1) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
2) Hong SB, Kim JW, Shin MS, et al. Impact of family environment on the development of tic disorders : epidemiologic evidence for an association. Ann Clin Psychiatry 2013 ; 25 : 50-8.
PubMed
3) Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette's syndrome : a review. J Psychosom Res 2008 ; 65 : 487-96.
PubMed
4) 新井卓. 児童・思春期のチック・トゥレット症と周辺症状. 医学と薬学 2018 ; 75 : 25-9.
Medical*Online
P.25 掲載の参考文献
1) 濱本優, 金生由紀子. Tourette症に対する薬物療法のエビデンスと治療ガイドライン. 臨床精神薬理 2017 ; 20 : 665-70.
 
2) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
3) Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of Tic disorders : pharmacotherapy. Can J Psychiatry 2012 ; 57 : 133-43.
PubMed
4) Roessner V, Plessen KJ, Rothenberger A, et al. ; European clinical guidelines for Tourette syndrome and other tic disorders. Part II : pharmacological treatment. Eur Child Adolesc Psychiatry 2011 ; 20 : 173-96.
PubMed
5) 金生由紀子. チック症, 吃音. 小児科診療 2018 ; 81 : 902-4.
Medical*Online
6) Hamamoto Y, Fujio M, Nonaka M, Matsuda N, Kono T, Kano Y. Expert consensus on pharmacotherapy for tic disorders in Japan. Brain Dev 2019 ; 41 : 501-6.
PubMed
7) Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 907-15.
PubMed
8) Mills S, Hedderly T. A guide to childhood motor stereotypies, tic disorders and the tourette spectrum for the primary care practitioner. Ulster Med J 2014 ; 83 : 22-30.
PubMed
9) Zheng Y, Zhang ZJ, Han XM, et al. A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome : a randomized controlled trial. J Child Psychol Psychiatry 2016 ; 57 : 74-83.
PubMed
10) 岩間正文, 入山恵津子. 慢性チック症に対する漢方エキス剤の改善効果. 漢方と最新治療 2019 ; 28 : 84-8.
Medical*Online
11) 岩間正文. 小児漢方の現状と未来 当院における小児漢方治療の現状 小建中湯, 柴胡桂枝湯, 抑肝散の成績を中心に. 日本小児東洋医学会誌 2015 ; 28 : 42-5.
 
12) de Caires S, Steenkamp V. Use of Yokukansan (TJ-54) in the treatment of neurological disorders : a review. Phytother Res 2010 ; 24 : 1265-70.
PubMed
13) Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents with Tourette's Disorder. https://clinicaltrials.gov/ct2/show/NCT03564132
 
14) 木全かおり. 繰り返すチック症状に抑肝散加陳皮半夏が著効した一例. Phil 漢方 2019 ; 77 : 4-5.
 
P.29 掲載の参考文献
1) Day M, Clarke SA, Castillo-Eito L, Rowe R. Psychoeducation for Children with Chronic Conditions : A Systematic Review and Meta-analysis. J Pediatr Psychol 2020 ; 45 : 386-98.
PubMed
2) Verdellen C, van de Griendt J, Hartmann A, Murphy T ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
 
3) Yates R, Edwards K, King J, et al. Habit reversal training and educational group treatments for children with tourette syndrome : A preliminary randomised controlled trial. Behav Res Ther 2016 ; 80 : 43-50.
PubMed
4) Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 2018 ; 9 : 100.
PubMed
5) Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder : a randomized controlled trial. JAMA 2010 ; 303 : 1929-37.
PubMed
6) Sukhodolsky DG, Woods DW, Piacentini J, et al. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology 2017 ; 88 : 1029-36.
PubMed
7) Bergin A, Waranch HR, Brown J, Carson K, Singer HS. Relaxation therapy in Tourette syndrome : a pilot study. Pediatr Neurol 1998 ; 18 : 136-42.
PubMed
8) Sukhodolsky DG, Vitulano LA, Carroll DH, McGuire J, Leckman JF, Scahill L. Randomized trial of anger control training for adolescents with Tourette's syndrome and disruptive behavior. J Am Acad Child Adolesc Psychiatry 2009 ; 48 : 413-21.
PubMed
9) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
10) Scahill L, Sukhodolsky DG, Bearss K, et al. Randomized trial of parent management training in children with tic disorders and disruptive behavior. J Child Neurol 2006 ; 21 : 650-6.
PubMed
11) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
12) Chen CW, Wang HS, Chang HJ, Hsueh CW. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with tourette's syndrome : A randomized controlled trial. J Adv Nurs 2020 ; 76 : 903-15.
PubMed
13) Zimmerman-Brenner S, Pilowsky-Peleg T, Rachamim L, et al. Group behavioral interventions for tics and comorbid symptoms in children with chronic tic disorders. Eur Child Adolesc Psychiatry 2022 ; 31 : 637-48.
PubMed
14) Rachamim L, Zimmerman-Brenner S, Rachamim O, Mualem H, Zingboim N, Rotstein M. Internet-based guided self-help comprehensive behavioral intervention for tics (ICBIT) for youth with tic disorders : a feasibility and effectiveness study with 6 month-follow-up. Eur Child Adolesc Psychiatry 2022 ; 31 : 275-87.
PubMed
15) Himle MB, Freitag M, Walther M, Franklin SA, Ely L, Woods DW. A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders. Behav Res Ther 2012 ; 50 : 565-70.
PubMed
16) Ricketts EJ, Bauer CC, Ran D, Himle MB, Woods DW. Pilot Open Case Series of Voice over Internet Protocol-delivered Assessment and Behavior Therapy for Chronic Tic Disorders. Cogn Behav Pract 2016 ; 23 : 40-50.
PubMed
17) Norwood C, Moghaddam NG, Malins S, Sabin-Farrell R. Working alliance and outcome effectiveness in videoconferencing psychotherapy : A systematic review and noninferiority meta-analysis. Clin Psychol Psychother 2018 ; 25 : 797-808.
PubMed
18) Inoue T, Togashi K, Iwanami J, Woods DW, Sakuta R. Open-case series of a remote administration and group setting comprehensive behavioral intervention for tics (RG-CBIT) : A pilot trial. Front Psychiatry 2022 ; 13 : 890866.
PubMed
P.33 掲載の参考文献
1) Freeeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome : selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000 ; 42 : 436-47.
 
2) Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P. Health related quality of life in children with Tourette Syndrome. Neurology 2007 ; 68 (Suppl 1) : A294.
 
3) Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001 ; 158 : 1067-74.
PubMed
4) Rizzo R, Gulisano M, Cali PV, Curatolo P. Tourette Syndrome and comorbid ADHD : current pharmacological treatment options. Eur J Paediatr Neurol 2013 ; 17 : 421-8.
PubMed
5) Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005 ; 65 : 1941-9.
PubMed
6) Tourette's Syndrome Study Group. Treatment of ADHD in children with tics : a randomized controlled trial. Neurology 2002 ; 58 : 527-36.
 
7) Osland ST, Steeves TDL, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev 2018 ; 6 : CD007990.
 
8) Cohen SC, Mulqueen JM, Ferracioli-Oda E, et al. Meta-Analysis : Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. J Am Acad Child Adolesc Psychiatry 2015 ; 54 : 728-36.
PubMed
9) Erenberg G. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication : a critical review. Semin Pediatr Neurol 2005 ; 12 : 217-21.
PubMed
P.35 掲載の参考文献
1) Vertigan AE, Murad MH, Pringsheim T, et al. Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children : CHEST Guideline and Expert Panel Report. Chest 2015 ; 148 : 24-31.
 
2) Evans J, Seri S, Cavanna AE. The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan : a systematic review. Eur Child Adolesc Psychiatry 2016 ; 25 : 939-48.
PubMed
3) Erbilgin Gun S, Kilincaslan A. Quality of Life Among Children and Adolescents With Tourette Disorder and Comorbid ADHD : A Clinical Controlled Study. J Atten Disord 2019 ; 23 : 817-27.
PubMed
4) Eddy CM, Cavanna AE, Gulisano M, et al. Clinical correlates of quality of life in Tourette syndrome. Mov Disord 2011 ; 26 : 735-8.
PubMed
5) Fernandez de la Cruz L, Rydell M, Runeson B, et al. Suicide in Tourette's and Chronic Tic Disorders. Biol Psychiatry 2017 ; 82 : 111-8.
PubMed
6) Seragni G, Chiappedi M, Bettinardi B, et al. Habit reversal training in children and adolescents with chronic tic disorders : an Italian randomized, single-blind pilot study. Minerva Pediatr 2018 ; 70 : 5-11.
PubMed
7) McGuire JF, Arnold E, Park JM, et al. Living with tics : reduced impairment and improved quality of life for youth with chronic tic disorders. Psychiatry Res 2015 ; 225 : 571-9.
PubMed
8) Wang HS, Kuo MF. Tourette's syndrome in Taiwan : an epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev 2003 ; 25 (Suppl 1) : S29-31.
 
P.37 掲載の参考文献
1) Sethi NK, Labar D, Torgovnick J. Myoclonic epilepsy masquerading as a tic disorder. Clin Neurol Neurosurg 2007 ; 109 : 509-11.
PubMed
2) Kent L, Blake A, Whitehouse W. Eyelid myoclonia with absences : phenomenology in children. Seizure 1998 ; 7 : 193-9.
PubMed
3) Koelfen W, Schultze C, Varnholt V. Ungewohnliche Symptome bei Hirntumoren im Kindesalter [Unusual symptoms in brain tumors in childhood]. Monatsschr Kinderheilkd 1993 ; 141 : 133-6.
PubMed
4) Brasic JR. Differentiating myoclonus from tics. Psychol Rep 2000 ; 86 : 155-6.
PubMed
5) Lacey DJ. Diagnosis of Tourette syndrome in childhood. The need for heightened awareness. Clin Pediatr (Phila) 1986 ; 25 : 433-5.
PubMed
6) Matoth I, Taustein I, Kay BS, Shapira YA. Overuse of EEG in the evaluation of common neurologic conditions. Pediatr Neurol 2002 ; 27 : 378-83.
PubMed
7) Miller AM, Bansal R, Hao X, et al. Enlargement of thalamic nuclei in Tourette syndrome. Arch Gen Psychiatry 2010 ; 67 : 955-64.
PubMed
8) Ludolph AG, Pinkhardt EH, Tebartz van Elst L, et al. Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity? Dev Med Child Neurol 2008 ; 50 : 524-9.
PubMed
9) Peterson BS, Choi HA, Hao X, et al. Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry 2007 ; 64 : 1281-91.
PubMed
10) Sowell ER, Kan E, Yoshii J, et al. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 2008 ; 11 : 637-9.
PubMed
11) Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005 ; 65 : 1253-8.
PubMed
12) Xu D, Hao X, Bansal R, et al. Unifying the analyses of anatomical and diffusion tensor images using volume-preserved warping. J Magn Reson Imaging 2007 ; 25 : 612-24.
 
13) Wolff N, Luehr I, Sender J, et al. A DTI study on the corpus callosum of treatment-naive boys with 'pure' Tourette syndrome. Psychiatry Res Neuroimaging 2016 ; 247 : 1-8.
 
14) Makki MI, Behen M, Bhatt A, Wilson B, Chugani HT. Microstructural abnormalities of striatum and thalamus in children with Tourette syndrome. Mov Disord 2008 ; 23 : 2349-56.
PubMed
15) Liu Y, Wang J, Zhang J, et al. Altered Spontaneous Brain Activity in Children with Early Tourette Syndrome : a Resting-state fMRI Study. Sci Rep 2017 ; 7 : 4808.
 
16) Wen H, Liu Y, Rekik I, et al. Combining Disrupted and Discriminative Topological Properties of Functional Connectivity Networks as Neuroimaging Biomarkers for Accurate Diagnosis of Early Tourette Syndrome Children. Mol Neurobiol 2018 ; 55 : 3251-69.
 
17) Liao W, Yu Y, Miao HH, Feng YX, Ji GJ, Feng JH. Inter-hemispheric Intrinsic Connectivity as a Neuromarker for the Diagnosis of Boys with Tourette Syndrome. Mol Neurobiol 2017 ; 54 : 2781-9.
 
18) Greene DJ, Church JA, Dosenbach NU, et al. Multivariate pattern classification of pediatric Tourette syndrome using functional connectivity MRI. Dev Sci 2016 ; 19 : 581-98.
 
P.39 掲載の参考文献
1) Conelea CA, Walther MR, Freeman JB, et al. Tic-related obsessive-compulsive disorder (OCD) : phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. J Am Acad Child Adolesc Psychiatry 2014 ; 53 : 1308-16.
 
2) Skarphedinsson G, Compton S, Thomsen PH, et al. Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy. J Child Adolesc Psychopharmacol 2015 ; 25 : 432-9.
PubMed
3) March JS, Franklin ME, Leonard H, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007 ; 61 : 344-7.
 
P.41 掲載の参考文献
1) Verdellen C, van de Griendt J, Hartmann A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
PubMed
2) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioral therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
3) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
4) Ganos C, Martino D, Pringsheim T. Tics in the Pediatric Population : Pragmatic Management. Mov Disord Clin Pract 2017 ; 4 : 160-72.
PubMed
5) Kepley HO, Conners S. Management of learning and school difficulties in children with Tourette syndrome. In : Woods DW, Piacentini JC, Walkup JT (eds). Treating Tourette syndrome and tic disorders : a guide for practitioners. New York : Guilford Press, 2007 : 242-64.
 
6) Friedrich S, Morgan SB, Devine C. Children's attitudes and behavioral intentions toward a peer with Tourette syndrome. J Pediatr Psychol 1996 ; 21 : 307-19.
 
7) Woods DW, Marcks BA. Controlled evaluation of an educational intervention used to modify peer attitudes and behavior toward persons with Tourette's Syndrome. Behav Modif 2005 ; 29 : 900-12.
PubMed
8) Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 896-906.
PubMed
9) Murphy T, Heyman I. Group Work in Young People with Tourette Syndrome. Child Adolesc Ment Health 2017 ; 12 : 46-8.
 
P.46 掲載の参考文献
1) 濱本優, 金生由紀子. チック・トゥレット症の治療・支援 (3) 薬物療法. こころの科学 2017 ; 194 : 61-7.
 
2) Hamamoto Y, Fujio M, Nonaka M, Matsuda N, Kono T, Kano Y. Expert consensus on pharmacotherapy for tic disorders in Japan. Brain Dev 2019 ; 41 : 501-6.
PubMed
3) Seideman MF, Seideman TA. A Review of the Current Treatment of Tourette Syndrome. J Pediatr Pharmacol Ther 2020 ; 25 : 401-12.
PubMed
4) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
5) Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : pharmacotherapy. Can J Psychiatry 2012 ; 57 : 133-43.
PubMed
6) Roessner V, Plessen KJ, Rothenberger A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II : pharmacological treatment. Eur Child Adolesc Psychiatry 2011 ; 20 : 173-96.
PubMed
7) Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003 ; 60 : 1130-5.
PubMed
8) Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette syndrome : a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002 ; 22 : 31-9.
 
9) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
10) Yoo HK, Choi SH, Park S, Wang HR, Hong JP, Kim CY. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. J Clin Psychiatry 2007 ; 68 : 1088-93.
PubMed
11) Murphy TK, Mutch PJ, Reid JM, et al. Open label aripiprazole in the treatment of youth with tic disorders. J Child Adolesc Psychopharmacol 2009 ; 19 : 441-7.
 
12) Lyon GJ, Samar S, Jummani R, et al. Aripiprazole in children and adolescents with Tourette's disorder : an open-label safety and tolerability study. J Child Adolesc Psychopharmacol 2009 ; 19 : 623-33.
 
13) Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf 2000 ; 23 : 35-56.
PubMed
14) Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010 ; 81 : 70-3.
PubMed
15) Awaad Y, Michon AM, Minarik S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005 ; 20 : 714-8.
PubMed
16) Fernandez-Jaen A, Fernandez-Mayoralas DM, Munoz-Jareno N, Calleja-Perez B. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. Eur J Paediatr Neurol 2009 ; 13 : 541-5.
PubMed
17) Hedderick EF, Morris CM, Singer HS. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009 ; 40 : 420-5.
PubMed
18) Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007 ; 22 : 1764-70.
PubMed
19) Nomura Y, Segawa M. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder : a hypothesis. Brain Dev 2003 ; 25 (Suppl 1) : S37-42.
 
20) Black KJ, Mink JW. Response to levodopa challenge in Tourette syndrome. Mov Disord 2000 ; 15 : 1194-8.
PubMed
21) 宮崎雅仁. チック障害. 小児内科 2010 ; 42 : 784-7.
Medical*Online
P.52 掲載の参考文献
1) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
2) Whittington C, Pennant M, Kendall T, et al. Practitioner Review : Treatments for Tourette syndrome in children and young people-a systematic review. J Child Psychol Psychiatry 2016 ; 57 : 988-1004.
 
3) Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 907-15.
PubMed
4) Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 896-906.
PubMed
5) Verdellen C, van de Griendt J, Hartmann A, Murphy T ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
 
6) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
7) Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 2018 ; 9 : 100.
PubMed
8) Sukhodolsky DG, Woods DW, Piacentini J, et al. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology 2017 ; 88 : 1029-36.
PubMed
9) Woods DW, Piacentini J, Chang SW, et al. Managing Tourette Syndrome : A Behavioral Intervention for Children and Adolescents : Therapist Guide. New York ; Oxford University Press, 2008.
 
10) Woods DW, Piacentini JC, Chang SW, Deckersbach T, Ginsburg GS, Peterson AL, et al. (著), 金生由紀子, 浅井逸郎 (監訳). チック症のための包括的行動的介入 (CBIT) セラピストガイド. 東京 : 丸善出版, 2018.
 
11) Yates R, Edwards K, King J, et al. Habit reversal training and educational group treatments for children with tourette syndrome : A preliminary randomised controlled trial. Behav Res Ther 2016 ; 80 : 43-50.
PubMed
12) Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980 ; 37 : 1343-7.
PubMed
13) Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA. Exposure with response prevention versus habit reversal in Tourettes's syndrome : a controlled study. Behav Res Ther 2004 ; 42 : 501-11.
 
14) van de Griendt JMTM, van Dijk MK, Verdellen CWJ, Verbraak MJPM. The effect of shorter exposure versus prolonged exposure on treatment outcome in Tourette syndrome and chronic tic disorders-an open trial. Int J Psychiatry Clin Pract 2018 ; 22 : 262-7.
PubMed
15) Cook CR, Blacher J. Evidence-Based Psychosocial Treatments for Tic Disorders. Clin Psychol Sci Pract 2007 ; 14 : 252-67.
 
16) van de Griendt JMTM, Verdellen CWJ, van Dijk MK, Verbraak MJ. Behavioural treatment of tics : habit reversal and exposure with response prevention. Neurosci Biobehav Rev 2013 ; 37 : 1172-7.
PubMed
17) Nissen JB, Kaergaard M, Laursen L, Parner E, Thomsen PH. Combined habit reversal training and exposure response prevention in a group setting compared to individual training : a randomized controlled clinical trial. Eur Child Adolesc Psychiatry 2019 ; 28 : 57-68.
 
18) Andren P, Aspvall K, Fernandez de la Cruz L, et al. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette's disorder : a pilot randomised controlled trial with long-term follow-up. BMJ Open 2019 ; 9 : e024685.
PubMed
P.54 掲載の参考文献
1) Rizzo R, Gulisano M, Cali PV, Curatolo P. Long term clinical course of Tourette syndrome. Brain Dev 2012 : 34 : 667-73.
PubMed
2) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioral therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
3) Verdellen C, van de Griendt J, Hartmann A, Murphy T ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioral and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
 
4) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
5) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 

資料 : 文献検索式・文献

P.55 掲載の参考文献
1) Shapiro AK, Shapiro ES, Young JG, Feinberg TE, eds. Gilles de la Tourette syndrome. 2nd ed. New York : Raven Press, 1988.
 
1) 梶龍兒, 編. 不随意運動の診断と治療, 改訂第2版. 東京 : 診断と治療社, 2016.
 
2) American Psychiatric Association, 著, 高橋三郎, 大野裕, 監訳, 日本精神神経学会 (日本語版用語監修). DSM-5 精神疾患の診断・統計マニュアル. 東京 : 医学書院, 2014.
 
2) Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome : selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000 ; 42 : 436-47.
PubMed
3) Shapiro AK, Shapiro ES, Young JG, Feinberg TE, eds. Gilles de la Tourette syndrome. 2nd ed. New York : Raven Press, 1988.
 
3) Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res 2009 ; 67 : 497-501.
PubMed
4) Cavanna AE, Critchley HD, Orth M, Stern JS, Young MB, Robertson MM. Dissecting the Gilles de la Tourette spectrum : a factor analytic study on 639 patients. J Neurol Neurosurg Psychiatry 2011 ; 82 : 1320-3.
 
4) Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale : initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989 ; 28 : 566-73.
PubMed
5) Stiede JT, Woods DW. Pediatric Prevention : Tic Disorders. Pediatr Clin North Am 2020 ; 67 : 547-57.
PubMed
5) Freeman R. Tics and Tourette Syndrome : Key Clinical Perspectives. London : Mac Keith Press, 2015.
 
6) 稲見茉莉, 金生由紀子. チック症の評価. 小児科臨床 2019 ; 72 (増刊) : 1331-4.
 
6) Bernard BA, Stebbins GT, Siegel S, et al. Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord 2009 ; 24 : 1070-3.
PubMed
7) Leckman JF, Zhang H, Vitale A, et al. Course of tic severity in Tourette syndrome : the first two decades. Pediatrics 1998 ; 102 : 14-9.
PubMed
7) Robertson MM, Althoff RR, Hafez A, Pauls DL. Principal components analysis of a large cohort with Tourette syndrome. Br J Psychiatry 2008 ; 193 : 31-6.
PubMed
8) Freeman RD, Zinner SH, Muller-Vahl KR, et al. Coprophenomena in Tourette syndrome. Dev Med Child Neurol 2009 ; 51 : 218-27.
PubMed
8) Rizzo R, Gulisano M, Cali PV, Curatolo P. Long term clinical course of Tourette syndrome. Brain Dev 2012 ; 34 : 667-73.
PubMed
9) Kuwabara H, Kono T, Shimada T, Kano Y. Factors affecting clinicians' decision as to whether to prescribe psychotropic medications or not in treatment of tic disorders. Brain Dev 2012 ; 34 : 39-44.
PubMed
9) Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry 1993 ; 150 : 98-102.
PubMed
10) Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary : treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 896-906.
PubMed
P.56 掲載の参考文献
1) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
2) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
3) Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 2018 ; 9 : 100.
PubMed
4) 金生由紀子. チック症, 吃音. 小児科診療 2018 ; 81 : 902-4.
Medical*Online
5) Hassan N, Cavanna AE. The prognosis of Tourette syndrome : implications for clinical practice. Funct Neurol 2012 ; 27 : 23-7.
PubMed
P.57 掲載の参考文献
1) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
1) 濱本優, 金生由紀子. Tourette症に対する薬物療法のエビデンスと治療ガイドライン. 臨床精神薬理 2017 ; 20 : 665-70.
 
2) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
2) Hong SB, Kim JW, Shin MS, et al. Impact of family environment on the development of tic disorders : epidemiologic evidence for an association. Ann Clin Psychiatry 2013 ; 25 : 50-8.
PubMed
3) Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of Tic disorders : pharmacotherapy. Can J Psychiatry 2012 ; 57 : 133-43.
PubMed
3) Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette's syndrome : a review. J Psychosom Res 2008 ; 65 : 487-96.
PubMed
4) 新井卓. 児童・思春期のチック・トゥレット症と周辺症状. 医学と薬学 2018 ; 75 : 25-9.
Medical*Online
4) Roessner V, Plessen KJ, Rothenberger A, et al. ; European clinical guidelines for Tourette syndrome and other tic disorders. Part II : pharmacological treatment. Eur Child Adolesc Psychiatry 2011 ; 20 : 173-96.
PubMed
5) 金生由紀子. チック症, 吃音. 小児科診療 2018 ; 81 : 902-4.
Medical*Online
6) Hamamoto Y, Fujio M, Nonaka M, Matsuda N, Kono T, Kano Y. Expert consensus on pharmacotherapy for tic disorders in Japan. Brain Dev 2019 ; 41 : 501-6.
PubMed
7) Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 907-15.
PubMed
8) Mills S, Hedderly T. A guide to childhood motor stereotypies, tic disorders and the tourette spectrum for the primary care practitioner. Ulster Med J 2014 ; 83 : 22-30.
PubMed
9) Zheng Y, Zhang ZJ, Han XM, et al. A proprietary herbal medicine (5-Ling Granule) for Tourette syndrome : a randomized controlled trial. J Child Psychol Psychiatry 2016 ; 57 : 74-83.
PubMed
10) 岩間正文, 入山恵津子. 慢性チック症に対する漢方エキス剤の改善効果. 漢方と最新治療 2019 ; 28 : 84-8.
Medical*Online
11) 岩間正文. 小児漢方の現状と未来 当院における小児漢方治療の現状 小建中湯, 柴胡桂枝湯, 抑肝散の成績を中心に. 日本小児東洋医学会誌 2015 ; 28 : 42-5.
 
12) de Caires S, Steenkamp V. Use of Yokukansan (TJ-54) in the treatment of neurological disorders : a review. Phytother Res 2010 ; 24 : 1265-70.
PubMed
13) Evaluating the Efficacy and Safety of Yi-Gan San in Children and Adolescents with Tourette's Disorder. https://clinicaltrials.gov/ct2/show/NCT03564132
 
14) 木全かおり. 繰り返すチック症状に抑肝散加陳皮半夏が著効した一例. Phil 漢方 2019 ; 77 : 4-5.
 
P.58 掲載の参考文献
1) Day M, Clarke SA, Castillo-Eito L, Rowe R. Psychoeducation for Children with Chronic Conditions : A Systematic Review and Meta-analysis. J Pediatr Psychol 2020 ; 45 : 386-98.
PubMed
2) Verdellen C, van de Griendt J, Hartmann A, Murphy T ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
 
3) Yates R, Edwards K, King J, et al. Habit reversal training and educational group treatments for children with tourette syndrome : A preliminary randomised controlled trial. Behav Res Ther 2016 ; 80 : 43-50.
PubMed
4) Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 2018 ; 9 : 100.
PubMed
5) Piacentini J, Woods DW, Scahill L, et al. Behavior therapy for children with Tourette disorder : a randomized controlled trial. JAMA 2010 ; 303 : 1929-37.
PubMed
6) Sukhodolsky DG, Woods DW, Piacentini J, et al. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology 2017 ; 88 : 1029-36.
PubMed
7) Bergin A, Waranch HR, Brown J, Carson K, Singer HS. Relaxation therapy in Tourette syndrome : a pilot study. Pediatr Neurol 1998 ; 18 : 136-42.
PubMed
8) Sukhodolsky DG, Vitulano LA, Carroll DH, McGuire J, Leckman JF, Scahill L. Randomized trial of anger control training for adolescents with Tourette's syndrome and disruptive behavior. J Am Acad Child Adolesc Psychiatry 2009 ; 48 : 413-21.
PubMed
9) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
10) Scahill L, Sukhodolsky DG, Bearss K, et al. Randomized trial of parent management training in children with tic disorders and disruptive behavior. J Child Neurol 2006 ; 21 : 650-6.
PubMed
11) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
12) Chen CW, Wang HS, Chang HJ, Hsueh CW. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with tourette's syndrome : A randomized controlled trial. J Adv Nurs 2020 ; 76 : 903-15.
PubMed
13) Zimmerman-Brenner S, Pilowsky-Peleg T, Rachamim L, et al. Group behavioral interventions for tics and comorbid symptoms in children with chronic tic disorders. Eur Child Adolesc Psychiatry 2022 ; 31 : 637-48.
PubMed
14) Rachamim L, Zimmerman-Brenner S, Rachamim O, Mualem H, Zingboim N, Rotstein M. Internet-based guided self-help comprehensive behavioral intervention for tics (ICBIT) for youth with tic disorders : a feasibility and effectiveness study with 6 month-follow-up. Eur Child Adolesc Psychiatry 2022 ; 31 : 275-87.
PubMed
15) Himle MB, Freitag M, Walther M, Franklin SA, Ely L, Woods DW. A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders. Behav Res Ther 2012 ; 50 : 565-70.
PubMed
16) Ricketts EJ, Bauer CC, Ran D, Himle MB, Woods DW. Pilot Open Case Series of Voice over Internet Protocol-delivered Assessment and Behavior Therapy for Chronic Tic Disorders. Cogn Behav Pract 2016 ; 23 : 40-50.
PubMed
17) Norwood C, Moghaddam NG, Malins S, Sabin-Farrell R. Working alliance and outcome effectiveness in videoconferencing psychotherapy : A systematic review and noninferiority meta-analysis. Clin Psychol Psychother 2018 ; 25 : 797-808.
PubMed
18) Inoue T, Togashi K, Iwanami J, Woods DW, Sakuta R. Open-case series of a remote administration and group setting comprehensive behavioral intervention for tics (RG-CBIT) : A pilot trial. Front Psychiatry 2022 ; 13 : 890866.
PubMed
P.59 掲載の参考文献
1) Freeeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome : selected findings from 3,500 individuals in 22 countries. Dev Med Child Neurol 2000 ; 42 : 436-47.
 
2) Pringsheim T, Lang A, Kurlan R, Pearce M, Sandor P. Health related quality of life in children with Tourette Syndrome. Neurology 2007 ; 68 (Suppl 1) : A294.
 
3) Scahill L, Chappell PB, Kim YS, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001 ; 158 : 1067-74.
PubMed
4) Rizzo R, Gulisano M, Cali PV, Curatolo P. Tourette Syndrome and comorbid ADHD : current pharmacological treatment options. Eur J Paediatr Neurol 2013 ; 17 : 421-8.
PubMed
5) Allen AJ, Kurlan RM, Gilbert DL, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005 ; 65 : 1941-9.
PubMed
6) Tourette's Syndrome Study Group. Treatment of ADHD in children with tics : a randomized controlled trial. Neurology 2002 ; 58 : 527-36.
 
7) Osland ST, Steeves TDL, Pringsheim T. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database Syst Rev 2018 ; 6 : CD007990.
 
8) Cohen SC, Mulqueen JM, Ferracioli-Oda E, et al. Meta-Analysis : Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials. J Am Acad Child Adolesc Psychiatry 2015 ; 54 : 728-36.
PubMed
9) Erenberg G. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication : a critical review. Semin Pediatr Neurol 2005 ; 12 : 217-21.
PubMed
P.60 掲載の参考文献
1) Vertigan AE, Murad MH, Pringsheim T, et al. Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children : CHEST Guideline and Expert Panel Report. Chest 2015 ; 148 : 24-31.
 
1) Sethi NK, Labar D, Torgovnick J. Myoclonic epilepsy masquerading as a tic disorder. Clin Neurol Neurosurg 2007 ; 109 : 509-11.
PubMed
2) Evans J, Seri S, Cavanna AE. The effects of Gilles de la Tourette syndrome and other chronic tic disorders on quality of life across the lifespan : a systematic review. Eur Child Adolesc Psychiatry 2016 ; 25 : 939-48.
PubMed
2) Kent L, Blake A, Whitehouse W. Eyelid myoclonia with absences : phenomenology in children. Seizure 1998 ; 7 : 193-9.
PubMed
3) Erbilgin Gun S, Kilincaslan A. Quality of Life Among Children and Adolescents With Tourette Disorder and Comorbid ADHD : A Clinical Controlled Study. J Atten Disord 2019 ; 23 : 817-27.
PubMed
3) Koelfen W, Schultze C, Varnholt V. Ungewohnliche Symptome bei Hirntumoren im Kindesalter [Unusual symptoms in brain tumors in childhood]. Monatsschr Kinderheilkd 1993 ; 141 : 133-6.
PubMed
4) Brasic JR. Differentiating myoclonus from tics. Psychol Rep 2000 ; 86 : 155-6.
PubMed
4) Eddy CM, Cavanna AE, Gulisano M, et al. Clinical correlates of quality of life in Tourette syndrome. Mov Disord 2011 ; 26 : 735-8.
PubMed
5) Lacey DJ. Diagnosis of Tourette syndrome in childhood. The need for heightened awareness. Clin Pediatr (Phila) 1986 ; 25 : 433-5.
PubMed
5) Fernandez de la Cruz L, Rydell M, Runeson B, et al. Suicide in Tourette's and Chronic Tic Disorders. Biol Psychiatry 2017 ; 82 : 111-8.
PubMed
6) Seragni G, Chiappedi M, Bettinardi B, et al. Habit reversal training in children and adolescents with chronic tic disorders : an Italian randomized, single-blind pilot study. Minerva Pediatr 2018 ; 70 : 5-11.
PubMed
6) Matoth I, Taustein I, Kay BS, Shapira YA. Overuse of EEG in the evaluation of common neurologic conditions. Pediatr Neurol 2002 ; 27 : 378-83.
PubMed
7) McGuire JF, Arnold E, Park JM, et al. Living with tics : reduced impairment and improved quality of life for youth with chronic tic disorders. Psychiatry Res 2015 ; 225 : 571-9.
PubMed
7) Miller AM, Bansal R, Hao X, et al. Enlargement of thalamic nuclei in Tourette syndrome. Arch Gen Psychiatry 2010 ; 67 : 955-64.
PubMed
8) Wang HS, Kuo MF. Tourette's syndrome in Taiwan : an epidemiological study of tic disorders in an elementary school at Taipei County. Brain Dev 2003 ; 25 (Suppl 1) : S29-31.
 
8) Ludolph AG, Pinkhardt EH, Tebartz van Elst L, et al. Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity? Dev Med Child Neurol 2008 ; 50 : 524-9.
PubMed
9) Peterson BS, Choi HA, Hao X, et al. Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. Arch Gen Psychiatry 2007 ; 64 : 1281-91.
PubMed
10) Sowell ER, Kan E, Yoshii J, et al. Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci 2008 ; 11 : 637-9.
PubMed
11) Bloch MH, Leckman JF, Zhu H, Peterson BS. Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology 2005 ; 65 : 1253-8.
PubMed
12) Xu D, Hao X, Bansal R, et al. Unifying the analyses of anatomical and diffusion tensor images using volume-preserved warping. J Magn Reson Imaging 2007 ; 25 : 612-24.
 
13) Wolff N, Luehr I, Sender J, et al. A DTI study on the corpus callosum of treatment-naive boys with 'pure' Tourette syndrome. Psychiatry Res Neuroimaging 2016 ; 247 : 1-8.
 
14) Makki MI, Behen M, Bhatt A, Wilson B, Chugani HT. Microstructural abnormalities of striatum and thalamus in children with Tourette syndrome. Mov Disord 2008 ; 23 : 2349-56.
PubMed
15) Liu Y, Wang J, Zhang J, et al. Altered Spontaneous Brain Activity in Children with Early Tourette Syndrome : a Resting-state fMRI Study. Sci Rep 2017 ; 7 : 4808.
 
16) Wen H, Liu Y, Rekik I, et al. Combining Disrupted and Discriminative Topological Properties of Functional Connectivity Networks as Neuroimaging Biomarkers for Accurate Diagnosis of Early Tourette Syndrome Children. Mol Neurobiol 2018 ; 55 : 3251-69.
 
17) Liao W, Yu Y, Miao HH, Feng YX, Ji GJ, Feng JH. Inter-hemispheric Intrinsic Connectivity as a Neuromarker for the Diagnosis of Boys with Tourette Syndrome. Mol Neurobiol 2017 ; 54 : 2781-9.
 
18) Greene DJ, Church JA, Dosenbach NU, et al. Multivariate pattern classification of pediatric Tourette syndrome using functional connectivity MRI. Dev Sci 2016 ; 19 : 581-98.
 
P.61 掲載の参考文献
1) Conelea CA, Walther MR, Freeman JB, et al. Tic-related obsessive-compulsive disorder (OCD) : phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. J Am Acad Child Adolesc Psychiatry 2014 ; 53 : 1308-16.
 
2) Skarphedinsson G, Compton S, Thomsen PH, et al. Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy. J Child Adolesc Psychopharmacol 2015 ; 25 : 432-9.
PubMed
3) March JS, Franklin ME, Leonard H, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007 ; 61 : 344-7.
 
P.62 掲載の参考文献
1) 濱本優, 金生由紀子. チック・トゥレット症の治療・支援 (3) 薬物療法. こころの科学 2017 ; 194 : 61-7.
 
1) Verdellen C, van de Griendt J, Hartmann A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
PubMed
2) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioral therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
2) Hamamoto Y, Fujio M, Nonaka M, Matsuda N, Kono T, Kano Y. Expert consensus on pharmacotherapy for tic disorders in Japan. Brain Dev 2019 ; 41 : 501-6.
PubMed
3) Seideman MF, Seideman TA. A Review of the Current Treatment of Tourette Syndrome. J Pediatr Pharmacol Ther 2020 ; 25 : 401-12.
PubMed
3) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
4) Ganos C, Martino D, Pringsheim T. Tics in the Pediatric Population : Pragmatic Management. Mov Disord Clin Pract 2017 ; 4 : 160-72.
PubMed
4) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
5) Pringsheim T, Doja A, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : pharmacotherapy. Can J Psychiatry 2012 ; 57 : 133-43.
PubMed
5) Kepley HO, Conners S. Management of learning and school difficulties in children with Tourette syndrome. In : Woods DW, Piacentini JC, Walkup JT (eds). Treating Tourette syndrome and tic disorders : a guide for practitioners. New York : Guilford Press, 2007 : 242-64.
 
6) Friedrich S, Morgan SB, Devine C. Children's attitudes and behavioral intentions toward a peer with Tourette syndrome. J Pediatr Psychol 1996 ; 21 : 307-19.
 
6) Roessner V, Plessen KJ, Rothenberger A, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II : pharmacological treatment. Eur Child Adolesc Psychiatry 2011 ; 20 : 173-96.
PubMed
7) Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003 ; 60 : 1130-5.
PubMed
7) Woods DW, Marcks BA. Controlled evaluation of an educational intervention used to modify peer attitudes and behavior toward persons with Tourette's Syndrome. Behav Modif 2005 ; 29 : 900-12.
PubMed
8) Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette syndrome : a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002 ; 22 : 31-9.
 
8) Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 896-906.
PubMed
9) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
9) Murphy T, Heyman I. Group Work in Young People with Tourette Syndrome. Child Adolesc Ment Health 2017 ; 12 : 46-8.
 
10) Yoo HK, Choi SH, Park S, Wang HR, Hong JP, Kim CY. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders. J Clin Psychiatry 2007 ; 68 : 1088-93.
PubMed
11) Murphy TK, Mutch PJ, Reid JM, et al. Open label aripiprazole in the treatment of youth with tic disorders. J Child Adolesc Psychopharmacol 2009 ; 19 : 441-7.
 
12) Lyon GJ, Samar S, Jummani R, et al. Aripiprazole in children and adolescents with Tourette's disorder : an open-label safety and tolerability study. J Child Adolesc Psychopharmacol 2009 ; 19 : 623-33.
 
13) Wong IC, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf 2000 ; 23 : 35-56.
PubMed
14) Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2010 ; 81 : 70-3.
PubMed
15) Awaad Y, Michon AM, Minarik S. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005 ; 20 : 714-8.
PubMed
16) Fernandez-Jaen A, Fernandez-Mayoralas DM, Munoz-Jareno N, Calleja-Perez B. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. Eur J Paediatr Neurol 2009 ; 13 : 541-5.
PubMed
17) Hedderick EF, Morris CM, Singer HS. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009 ; 40 : 420-5.
PubMed
18) Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007 ; 22 : 1764-70.
PubMed
19) Nomura Y, Segawa M. Neurology of Tourette's syndrome (TS) TS as a developmental dopamine disorder : a hypothesis. Brain Dev 2003 ; 25 (Suppl 1) : S37-42.
 
20) Black KJ, Mink JW. Response to levodopa challenge in Tourette syndrome. Mov Disord 2000 ; 15 : 1194-8.
PubMed
21) 宮崎雅仁. チック障害. 小児内科 2010 ; 42 : 784-7.
Medical*Online
P.63 掲載の参考文献
1) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 
2) Whittington C, Pennant M, Kendall T, et al. Practitioner Review : Treatments for Tourette syndrome in children and young people-a systematic review. J Child Psychol Psychiatry 2016 ; 57 : 988-1004.
 
3) Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 907-15.
PubMed
4) Pringsheim T, Okun MS, Muller-Vahl K, et al. Practice guideline recommendations summary : Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019 ; 92 : 896-906.
PubMed
5) Verdellen C, van de Griendt J, Hartmann A, Murphy T ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
 
6) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
7) Rizzo R, Pellico A, Silvestri PR, Chiarotti F, Cardona F. A Randomized Controlled Trial Comparing Behavioral, Educational, and Pharmacological Treatments in Youths With Chronic Tic Disorder or Tourette Syndrome. Front Psychiatry 2018 ; 9 : 100.
PubMed
8) Sukhodolsky DG, Woods DW, Piacentini J, et al. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology 2017 ; 88 : 1029-36.
PubMed
9) Woods DW, Piacentini J, Chang SW, et al. Managing Tourette Syndrome : A Behavioral Intervention for Children and Adolescents : Therapist Guide. New York ; Oxford University Press, 2008.
 
10) Woods DW, Piacentini JC, Chang SW, Deckersbach T, Ginsburg GS, Peterson AL, et al. (著), 金生由紀子, 浅井逸郎 (監訳). チック症のための包括的行動的介入 (CBIT) セラピストガイド. 東京 : 丸善出版, 2018.
 
11) Yates R, Edwards K, King J, et al. Habit reversal training and educational group treatments for children with tourette syndrome : A preliminary randomised controlled trial. Behav Res Ther 2016 ; 80 : 43-50.
PubMed
12) Bliss J. Sensory experiences of Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980 ; 37 : 1343-7.
PubMed
13) Verdellen CW, Keijsers GP, Cath DC, Hoogduin CA. Exposure with response prevention versus habit reversal in Tourettes's syndrome : a controlled study. Behav Res Ther 2004 ; 42 : 501-11.
 
14) van de Griendt JMTM, van Dijk MK, Verdellen CWJ, Verbraak MJPM. The effect of shorter exposure versus prolonged exposure on treatment outcome in Tourette syndrome and chronic tic disorders - an open trial. Int J Psychiatry Clin Pract 2018 ; 22 : 262-7.
PubMed
15) Cook CR, Blacher J. Evidence-Based Psychosocial Treatments for Tic Disorders. Clin Psychol Sci Pract 2007 ; 14 : 252-67.
 
16) van de Griendt JMTM, Verdellen CWJ, van Dijk MK, Verbraak MJ. Behavioural treatment of tics : habit reversal and exposure with response prevention. Neurosci Biobehav Rev 2013 ; 37 : 1172-7.
PubMed
17) Nissen JB, Kaergaard M, Laursen L, Parner E, Thomsen PH. Combined habit reversal training and exposure response prevention in a group setting compared to individual training : a randomized controlled clinical trial. Eur Child Adolesc Psychiatry 2019 ; 28 : 57-68.
 
18) Andren P, Aspvall K, Fernandez de la Cruz L, et al. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette's disorder : a pilot randomised controlled trial with long-term follow-up. BMJ Open 2019 ; 9 : e024685.
PubMed
P.64 掲載の参考文献
1) Rizzo R, Gulisano M, Cali PV, Curatolo P. Long term clinical course of Tourette syndrome. Brain Dev 2012 : 34 : 667-73.
PubMed
2) Steeves T, McKinlay BD, Gorman D, et al. Canadian guidelines for the evidence-based treatment of tic disorders : behavioral therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry 2012 ; 57 : 144-51.
PubMed
3) Verdellen C, van de Griendt J, Hartmann A, Murphy T ; ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III : behavioral and psychosocial interventions. Eur Child Adolesc Psychiatry 2011 ; 20 : 197-207.
 
4) Murphy TK, Lewin AB, Storch EA, Stock S ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry 2013 ; 52 : 1341-59.
PubMed
5) Hollis C, Pennant M, Cuenca J, et al. Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome : a systematic review and qualitative analysis. Health Technol Assess 2016 ; 20 : 1-450, vii-viii.
 

書評

最近チェックした商品履歴

Loading...